DGAP-News: Wide Impact of novoGI Nitinol Compression Anastomosis at the Annual Meeting of the American Society of Colorectal Surgeons (ASCRS) 2013
(firmenpresse) - novoGI Inc.
01.05.2013 09:39
---------------------------------------------------------------------------
Global Registry and Other New Clinical Endeavors Launched
ATLANTA, 2013-05-01 09:38 CEST (GLOBE NEWSWIRE) --
novoGI Inc today announced that its nitinol-based compression anastomosis
device was widely presented at the American Society of Colorectal Surgeons
(ASCRS) Annual Meeting on April 28 - May 1 at the Phoenix Convention Center in
Phoenix, Arizona. With more than 50 peer-reviewed publications and 10,000
procedures worldwide for the novoGI(tm) ColonRing, evidence demonstrates clinical
results for ease of use, healing processes, and successful outcomes in regard
to leak rates.
Data presented at ASCRS 2013 continue to substantiate that the novoGI(tm)
ColonRing is especially effective in lower anterior resection (LAR) procedures
with leak rates ranging from 1.9% to 4%.
Clinical presentations on compression anastomosis at ASCRS 2013 included:
-- Compression Anastomosis Is Associated With a Low Rate of Anastomotic
Leakage: Intermediate Results of WCCA RETROPRESS Study. Poster presentation
by WCCA Faculty members Stephen Cohen, MD, FACS, FASCRS (Atlanta Colon and
Rectal Surgery, PA, Atlanta, GA), Matthew Albert, MD, FACS, FASCRS (Florida
Hospital, Orlando, FL), Jose Dominguez, MD (Cox Medical Center Health, St.
Louis, MO), Domingo Galliano Jr, MD, FACS, FASCRS (Fawcett Memorial
Hospital, Port Charlotte, FL), and Michael Stamos, MD, FACS, FASCRS
(University of California, Irvine, Irvine, CA). Abstract P318.
-- Why Is Nitinol Compression Anastomosis Important? Presentation by Abe
Fingerhut, MD, DSc (hon), FACS, FRCPS (g), FRCS (Ed) (Department of
Surgery, University of Athens, Hippokrateon Hospital, Athens, Greece, WCCA
Training Committee Chair, WCCA Faculty) held Monday, April 29 at the novoGI
booth.
-- The WCCA Compression Anastomosis Registry: What, Why, and How? Presentation
by Anthony Senagore, MD, MBA, FACS (Keck School of Medicine, University of
Southern California, Los Angeles, CA, WCCA Registry Committee Chair, WCCA
Faculty) held Tuesday, April 30 at the novoGI booth.
On podium at ASCRS 2013, novoGI compression anastomosis technology was noted in
several sessions--including The Surgeon's Toolbox Symposium and Anastomotic
Techniques and Leaks Symposium --as an attractive alternative to surgical
stapling.
'We are especially encouraged by the growing body of solid clinical data as
well as the enthusiasm this week at ASCRS 2013 and at the recent World Congress
of Compression Anastomosis (WCCA) 2nd Annual Meeting held in Phoenix last
Friday,' Gavriel D. Meron, president and Chief Executive Officer of novoGI
commented, 'Our proprietary nitinol compression anastomosis technology is the
recommended device for LAR procedures. Leading colorectal surgeons are driving
new clinical endeavors to enable better patient care--such as the WCCA global
registry and the planning of the new COMPARE comparative, prospective, and
randomized multicenter trial comparing conventional circular staplers to the
novoGI(tm) ColonRing compression anastomosis device.'
About novoGI
novoGI is focused on providing an expanding range of solutions for GI disease
management through a globally branded, high quality, market driven company. The
US headquarters are in Atlanta, Georgia; research, development and
manufacturing facilities in Netanya, Israel; and its European headquarters are
near Paris, France. The company's website is www.novoGI.com.
NOVOGI, the NOVOGI logo, the GI logo, and DEFINING THE FUTURE are trademarks
and/or registered trademarks of novoGI Inc.
CONTACT: marcom(at)novoGI.com
www.novoGI.com
News Source: NASDAQ OMX
01.05.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: novoGI Inc.
Israel
Phone:
Fax:
E-mail:
Internet:
ISIN: US9902064198
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.05.2013 - 09:39 Uhr
Sprache: Deutsch
News-ID 254837
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 428 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Wide Impact of novoGI Nitinol Compression Anastomosis at the Annual Meeting of the American Society of Colorectal Surgeons (ASCRS) 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
novoGI Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
